IRT Platform (e.g., HRV)
Human Rhinovirus Infection
Research/Pre-clinicalActive
Key Facts
Indication
Human Rhinovirus Infection
Phase
Research/Pre-clinical
Status
Active
Company
About Biological Mimetics
Biological Mimetics is a private, pre-revenue biotechnology company with a 25+ year history, specializing in novel vaccine and diagnostic platforms. Its lead technologies include IRT (Immune Refocusing Technology) for creating more broadly protective vaccines and MDP (Manganese-Decapeptide-Phosphate) for pathogen inactivation, with an advanced program in ultraIPV (inactivated polio vaccine). The company also collaborates on FAST, a portable CRISPR-based diagnostic tool designed for low-resource settings. BMI operates through partnerships to advance its platforms toward the market.
View full company profile